Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transarterial Chemoembolization”

284 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 284 results

Not applicableStudy completedNCT01360255
What this trial is testing

AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE)

Who this might be right for
Hepatocellular Carcinoma
University Hospital Freiburg 70
Large-scale testing (Phase 3)Study completedNCT02973685
What this trial is testing

HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.

Who this might be right for
HepatoCellular Carcinoma
Sun Yat-sen University 315
Large-scale testing (Phase 3)UnknownNCT02338297
What this trial is testing

Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC

Who this might be right for
Carcinoma, Hepatocellular
Nanjing Medical University 236
Early research (Phase 1)UnknownNCT01721941
What this trial is testing

TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Scripps Clinic Cancer Center 20
Post-approval studies (Phase 4)UnknownNCT05416073
What this trial is testing

Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial ChemoembolizationHepatic Arterial Infusion Chemotherapy+1 more
The Second Affiliated Hospital of Chongqing Medical University 70
Large-scale testing (Phase 3)Study completedNCT04103398
What this trial is testing

TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaSorafenibTransarterial Chemoembolization
Sun Yat-sen University 162
Not applicableNot Yet RecruitingNCT07109336
What this trial is testing

Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Zhongda Hospital 790
Not applicableWithdrawnNCT03172559
What this trial is testing

Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto
Not applicableUnknownNCT03732235
What this trial is testing

TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer

Who this might be right for
Liver Metastasis Colon Cancer
Giammaria Fiorentini 50
Not applicableStudy completedNCT05121571
What this trial is testing

The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 114
Testing effectiveness (Phase 2)Study completedNCT03086564
What this trial is testing

A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT)

Who this might be right for
Hepatocellular Carcinoma
Yuehua Huang 70
Post-approval studies (Phase 4)Study completedNCT04015245
What this trial is testing

SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy

Who this might be right for
Hepatocellular Carcinoma
Chimei Medical Center 60
Post-approval studies (Phase 4)Study completedNCT03706157
What this trial is testing

Kinectics of Distribution of Doxorubicin-Lipiodol Emulsion in c-TACE

Who this might be right for
Hepato Cellular Carcinoma
University Hospital, Strasbourg, France 10
Not applicableStudy completedNCT02878109
What this trial is testing

DCE-MRI for Assessment of Response to TACE of HCC

Who this might be right for
Carcinoma, Hepatocellular
Centre hospitalier de l'Université de Montréal (CHUM) 40
Testing effectiveness (Phase 2)UnknownNCT05340231
What this trial is testing

An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)

Who this might be right for
Colorectal Cancer
Gang Wu 100
Not applicableStudy completedNCT03317483
What this trial is testing

DEB-TACE Treatment in 367 Liver Cancer Patients

Who this might be right for
Liver Cancer
Zhejiang Cancer Hospital 367
Testing effectiveness (Phase 2)Study completedNCT06071052
What this trial is testing

TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens

Who this might be right for
Liver Metastasis Colon Cancer
First Affiliated Hospital, Sun Yat-Sen University 21
Testing effectiveness (Phase 2)Study completedNCT01116635
What this trial is testing

Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of British Columbia 24
Testing effectiveness (Phase 2)Study completedNCT04997850
What this trial is testing

The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectableTransarterial ChemoembolizationTyrosine Kinase Inhibitor+1 more
Xinrui Zhu，MD 142
Early research (Phase 1)Study completedNCT01011010
What this trial is testing

Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
UNC Lineberger Comprehensive Cancer Center 11
Load More Results